Jessica Chubak, PhD
Assistant Investigator
206-287-2556
chubak.j@ghc.org
Recent publications
Curriculum vitae (CV)
Research interests and experience
- Cancer control: epidemiology; breast cancer; medication use; survivorship; secondary prevention; quality of life; automated data collection; screening
- Health services & economics: chronic illness management; translation of preventive care research into clinical practice
- Medication use & patient safety: pharmaceutical outcomes research; validation of pharmacy data resources
Jessica Chubak joined Group Health Research Institute (GHRI) in 2007 with a passion for epidemiology and translational research. With expertise in epidemiologic methods, pharmaco-epidemiology, and cancer, she is working with the Institute's cancer researchers to explore new inquiries in cancer survivorship.
Dr. Chubak participates in the HMO Cancer Research Network and several projects on medication use and cancer risk and prognosis. She is especially interested in evaluating programs and translating research into practices that improve health and health care.
Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand. This unique background has helped shape her commitment to moving research innovations into daily practice, especially for cancer survivors. She coordinates the cancer researchers' group at GHRI and hopes to build a research program in survivorship focused on preventing cancer death, recurrence, and late and long-term effects of cancer treatment. She aims to develop epidemiologic methods for large-scale research on managing care for cancer survivors.
Recent publications
Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to antidepressant medication use. Int J Cancer. 2010 Mar 15. [Epub ahead of print]. PubMed
Buist DS, Chubak J, Prout M, Yood MU, Bosco JL, Thwin SS, Gold HT, Owusu C, Field TS, Quinn VP, Wei F, Silliman RA. Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence. J Clin Oncol. 2009 Sep 20;27(27):4508-14. Epub 2009 Aug 17. PubMed
Hudson SV, Chubak J, Coups EJ, Blake-Gumbs L, Jacobsen PB, Neugut AI, Buist DS. Identifying key questions to advance research and practice in cancer survivorship follow-up care: a report from the ASPO Survivorship Interest Group. Cancer Epidemiol Biomarkers Prev. 2009;18(7):2152-4. PubMed
Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to use of acid suppressive medications. Pharmacoepidemiol Drug Saf. 2009 Jul;18(7):540-4. PubMed
Chubak J, Boudreau D, Rulyak S, Mandelson M. Colorectal cancer risk in relation to antidepressant use. Cancer Epidemiol Biomarkers Prev. 2009;18(2):692.
Chubak J, Bowles EJ, Terry MB, Trentham-Dietz A, Buist DS. Antidepressant medications and change in mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2009;18(2):676-9. Epub 2009 Feb 3. PubMed
Hawkins V, Foster-Schubert K, Chubak J, Sorensen B, Ulrich CM, Stancyzk FZ, Plymate S, Stanford J, White E, Potter JD, McTiernan A. Effect of exercise on serum sex hormones in men: a 12-month randomized clinical trial. Med Sci Sports Exerc. 2008;40(2):223-233.
Chubak J, Buist DS, Boudreau DM, Rossing MA, Lumley T, Weiss NS. Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Research and Treatment. 2008 Nov;112(1):123-32. Epub 2007 Dec 6. PubMed
Ulrich CM, Chubak J, McTiernan A. Re: Exercise, vitamins and respiratory tract infections. Am J Med. 2007 Dec;120(12):e19.
Chubak J, Doherty JA, Cushing-Haugen KL, Voigt LF, Saltzman BS, Hill DA, Beresford SAA, Weiss NS. Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy. Cancer Causes Control. 2007;18(9):1001-7. Epub 2007 Jul 25. PubMed
To view more publications, please see Dr. Chubak's CV.